Italian members of the European Parliament are fighting the European Medicines Agency’s relocation to the Netherlands.
Today could play a pivotal role in the CRISPR patent landscape in Europe.
European IP boutique firm Hoyng Rokh Monegier has announced that Benoît Strowel will succeed Willem Hoyng as managing partner.
Biopharmaceutical company MiMedx Group has settled a long-standing patent infringement dispute with the Musculoskeletal Transplant Foundation, Medline Industries and Liventa Bioscience.
Healthcare firm Nuvo Pharmaceuticals has announced the acquisition of Resultz from US company Piedmont Pharmaceuticals.
The US Department of Commerce (DOC) has said that there are “shortcomings” in China’s IP rights when it comes to the country’s pharmaceutical sector.
Regeneron Pharmaceuticals has formed a consortium with five other companies to fund the generation of exome sequence data from 500,000 volunteers in the UK.
Israel-based Teva Pharmaceuticals has signed a global licence agreement with Alder BioPharmaceuticals.
Allergan and the Native American tribe that acquired Allergan’s patents for Restasis have told the US Court of Appeals for the Federal Circuit that patents covering the dry eye treatment are valid.
The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness.